IBEXPERTS Ltd. and IBEXPERTS BV were founded in 2004 and in 2007, respectively and are managed by Dr. Rachel Kreisberg. Dr. Kreisberg is a bio-entrepreneur who specializes in carrying out ambitious, large-scale international projects. She has proven experience in managing international R&D projects, such as EU projects and technology transfer initiatives. In addition, she has a track record of initiating international projects such as the establishment of bioinformatics centers, some of which were part of an initiative of Israeli and Palestinian businessmen under the auspice of the World Bank, to promote peace through joint ventures.
Prior to founding IBEX, she has managed the Bioinformatics Unit of Tel Aviv University between 1998 and 2005 and she was one of the co-founders of the Israeli National Center of Bioinformatics Infrastructure (COBI), which was established in 2002. She has a Ph.D. in biology from Tel Aviv University, a M.Sc. in chemistry from the Technion and an MBA from Tel Aviv University. She was born in the Netherlands and speaks English, Dutch, Hebrew, German and French. In addition, she provides professional genealogy research services.

Mr. Guy Maayan joined IBEX in January 2007 as a financial officer. Mr. Maayan provides IBEX EU research consortia with comprehensive financial management services. Among others, He serves as the financial administrator of IBEX's FP6 EUROFLU project for which he carried out a dry run after 1 year, prepared the management reports, submitted it to the EU and administered the derived EC contribution, and addressed EUROFLU beneficiaries' inquiries regarding eligible costs, reporting, auditing, etc. He has a BA in Economy and an MA in Contemporary Middle East Studies from the Hebrew University of Jerusalem.

IBEX Company Culture
IBEX is named after a wild goat found in mountainous terrain. It is very agile in manoeuvering steep cliffs, is well adapted to minimalist conditions, stands on very strong legs and possesses an acute sense of hearing.

The IBEX team uses these same characteristics to offer its clients agility, market adaptability and strategic vision to enhance the R&D capabilities and profitability of an organization.